Terms: = Sarcomas AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Staging
1 results:
1. KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.
Clancy C; Burke JP; Coffey JC
Surg Oncol; 2013 Jun; 22(2):105-11. PubMed ID: 23473635
[TBL] [Abstract] [Full Text] [Related]
